Chikungunya, IgM
Understanding Chikungunya, IgM
What is Chikungunya, IgM?
A Chikungunya, IgM test is a blood test that helps to detect the presence of specific antibodies immunoglobulin M (IgM) produced by the body in response to the Chikungunya virus. It is used to screen a recent infection and helps in timely intervention.
Chikungunya is a mosquito-borne infection that can cause an abrupt onset of fever, often accompanied by joint pain and other symptoms such as muscle pain, headache, nausea, fatigue, and rash.
When an individual is infected with chikungunya virus, the immune system produces IgM antibodies as a response. A Chikungunya, IgM test examines the presence of these antibodies in the bloodstream, helping to confirm the recent exposure to the virus. As Chikungunya shares symptoms with other mosquito-borne diseases like dengue, malaria, and Zika, accurate diagnosis is challenging. A Chikungunya, IgM test is crucial for confirming the virus’s presence, ensuring an accurate diagnosis, and guiding appropriate management.
A Chikungunya, IgM test is most effective when conducted during the initial phase of infection i.e. within the first week of symptoms onset as it provides a crucial time window to identify the presence of Chikungunya IgM antibodies in the blood. This test is useful in regions where chikungunya is endemic or during periods of increased mosquito activity.
While there is no specific vaccine or treatment for chikungunya infection, early detection through a Chikungunya, IgM test helps manage the symptoms and prevent complications.
No special preparations are required to get tested with a Chikungunya, IgM test. However, inform your doctor about any recent travel to areas with chikungunya outbreaks and provide details about your symptoms. Also, tell about any medications or supplements you are taking, as they might affect the test results.
Lab test results may vary across different laboratories. Talk to your doctor about your specific test results. Abnormal test results require an expert interpretation, therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for proper understanding of the test results.
What is Chikungunya, IgM used for?
A Chikungunya, IgM test is done:
-
If you are experiencing symptoms such as high fever, joint pain, joint swelling, fatigue, rash, and muscle pain
-
To detect antibodies early for an early diagnosis of Chikungunya virus
-
After recent travel to Chikungunya endemic areas.
-
To monitor the spread and prevalence of the chikungunya virus in a population.
-
For pregnant women with symptoms, to manage and monitor the impact on mother and baby.
What does Chikungunya, IgM measure?
A Chikungunya, IgM test measures the presence of Immunoglobulin M (IgM) antibodies in the blood, specifically targeting the Chikungunya virus. These antibodies are produced in response to a recent Chikungunya infection, helping diagnose the active phase of the disease.
The Chikungunya, IgM test is a qualitative rapid immunochromatographic test for the detection of chikungunya IgM antibodies.
Answers to Patient Concerns & Frequently Asked Questions (FAQs) about Chikungunya, IgM
Frequently Asked Questions about Chikungunya, IgM
Q. What does a Chikungunya, IgM test do?
Q. Who should get a Chikungunya, IgM test?
Q. What should I do if my Chikungunya, IgM test results are positive?
Q. Can a Chikungunya, IgM test be used for prevention or vaccination purposes?
Q. What are the common symptoms of Chikungunya?
Q. Can the Chikungunya virus be transmitted from person to person?
Q. How long does Chikungunya last?
Q. Can I get Chikungunya more than once?
Q. How can I prevent Chikungunya infection?
Q. Is there any specific treatment available for Chikungunya?
Book a Chikungunya, IgM test at home near me
References
- Chikungunya [Internet]. WHO; 08 Dec. 2022 [Accessed 31 Jan. 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/chikungunya
- Chikungunya Virus [Internet]. CDC; 07 Dec. 2023 [Accessed 31 Jan. 2024]. Available from: https://www.cdc.gov/chikungunya/symptoms/index.html
- Chelluboina S, Robin S, Aswathyraj S, Arunkumar G. Persistence of antibody response in chikungunya. Virusdisease. 2019 Sep;30(3):469-473. [Accessed 31 Jan. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863990/#:~:text=Chikungunya%20is%20a%20mosquito%2Dborne,declines%20at%202%E2%80%933%20months.
- Chua CL, Sam IC, Chiam CW, Chan YF. The neutralizing role of IgM during early Chikungunya virus infection. PLoS One. 2017 Feb 9;12(2):e0171989. [Accessed 31 Jan. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300252/
- Ojeda Rodriguez JA, Haftel A, Walker, III JR. Chikungunya Fever. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534224/
- Vu DM, Jungkind D, Angelle Desiree LaBeaud. Chikungunya Virus. Clin Lab Med. 2017 Jun;37(2):371-382. [Accessed 31 Jan. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469677/
- Janeway CA Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. 5th edition. New York: Garland Science; 2001. The distribution and functions of immunoglobulin isotypes. Available from: [Accessed 31 Jan. 2024]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK27162/
- Johnson BW, Russell BJ, Goodman CH. Laboratory Diagnosis of Chikungunya Virus Infections and Commercial Sources for Diagnostic Assays. J Infect Dis. 2016 Dec 15;214(suppl 5):S471-S474. [Accessed 31 Jan. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657184/
Other tests
